quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:30:00·338d
NEWSRelease
Zomedica Corp. logo

Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution

ZOM· Zomedica Corp.
Health Care
Original source

Companies

  • ZOM
    Zomedica Corp.
    Health Care

Recent analyst ratings

  • Jan 6UpdateDawson James$6.00

Related

  • PR59d
    Diality Appoints Peter Donato as Chief Financial Officer
  • NEWS134d
    Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
  • NEWS141d
    Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
  • NEWS164d
    Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
  • NEWS169d
    Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
  • NEWS170d
    Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
  • NEWS183d
    Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
  • NEWS192d
    Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022